Introduction

Article Abstract:

A panel convened by the National Institute on Drug Abuse presents its recommendations for future research on the metabolic, endocrine, and gastrointestinal disorders in drug addicts and HIV patients. Much of the past research is reviewed in a special supplement to the October 1, 2000 issue of JAIDS.

Drug addicts, Drug abusers

---

HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors

Article Abstract:

Some HIV patients may also be infected with HTLV-1 or HTLV-2, which are retroviruses like HIV. In a survey of 499 HIV patients in Brazil, 6% were also infected with HTLV-1 and 7% were infected with HTLV-2. Intravenous drug use was the biggest risk factor for HTLV-1 and HTLV-2 infection.

Statistical Data Included, Statistics, HTLV-I infections, HTLV-II infections

---

No increased human herpesvirus 8 seroprevalence in patients with HIV-associated non-Hodgkin's lymphoma

Article Abstract:

Human herpesvirus 8 (HHV-8) does not appear to cause non-Hodgkin's lymphoma in HIV patients. In a study of 63 HIV patients with non-Hodgkin's lymphoma and 126 HIV patients without, 41% of the lymphoma patients tested positive for HHV-8 but so did 37% of the other group.

Health aspects, Causes of, Non-Hodgkin's lymphomas, Human herpesvirus 8

Similar abstracts:

• Abstracts: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. Effect of growth hormone treatment on the adult height of children with chronic renal failure
• Abstracts: Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial
• Abstracts: Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Secondary osteoporosis: the potential relevance of leptin and low body weight
• Abstracts: Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.